Abstract Background Prostate cancer (PCa) is a frequent malignant tumor worldwide with
high morbidity along with mortality. MicroRNAs (miRNAs) have been identified as key …

Introduction Aberrant glycosylation of proteins is an important hallmark in multiple cancers.
Prostate‐specific membrane antigen (PSMA), a highly glycosylated protein with 10 N‐linked …

Prostate cancer (PCa) appears among the most frequently diagnosed types of malignancies
in males. Because of the high demand and increasing detection rate of early PCa, alongside …

Introduction Prostate cancer (PCa) is known for its highly diverse clinical behavior, ranging
from low-risk, slow-growing tumors to aggressive and life-threatening forms. To avoid over …

High acceleration factors in radial magnetic resonance fingerprinting (MRF) of the prostate
lead to strong streak‐like artefacts from flow in the femoral blood vessels, possibly …

In this systematic review and meta‑analysis, the diagnostic performance of 68 Ga‑prostate‑
specific membrane antigen (PSMA) positron emission tomography (PET)/CT was compared …

Purpose To develop an early diagnosis model of prostate cancer based on clinical-
radiomics to improve the accuracy of imaging diagnosis of prostate cancer. Methods The …

Objective This work aims to examine the latest evidence on the impact of pre‐biopsy MRI, in
addition to prostate‐specific antigen (PSA) testing, on health outcomes and quality of life …

Prostate cancer is one of the most common tumors among the male population. Magnetic
resonance imaging (MRI), standardized by the PI-RADS version 2.1 scoring system, has a …

Multiparametric magnetic resonance imaging (mpMRI) plays a critical role in prostate cancer
(PCa) diagnosis, aiding in clinical trial evaluation and personalized treatment planning. We …